Travis Steed
Stock Analyst at Bank of America Securities
(3.87)
# 2,052
Out of 5,090 analysts
653
Total ratings
55.6%
Success rate
3.6%
Average return
Main Sectors:
Stocks Rated by Travis Steed
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Reiterated: Buy | $54 | $41.98 | +28.63% | 61 | Oct 30, 2026 | |
| MDT Medtronic | Reiterated: Buy | $110 | $96.54 | +13.94% | 56 | Oct 30, 2026 | |
| SYK Stryker | Reiterated: Buy | n/a | $291.86 | - | 36 | Oct 30, 2026 | |
| AXGN Axogen | Reiterated: Buy | $52 → $62 | $49.37 | +25.58% | 6 | Oct 29, 2026 | |
| BLCO Bausch + Lomb | Reiterated: Sell | n/a | $20.00 | - | 6 | Oct 29, 2026 | |
| GEHC GE HealthCare Technologies | Reiterated: Hold | $74 → $84 | $76.57 | +9.70% | 10 | Oct 28, 2026 | |
| BBNX Beta Bionics | Reiterated: Hold | $20 → $22 | $16.75 | +31.34% | 16 | Oct 27, 2026 | |
| SOLV Solventum | Reiterated: Hold | $95 → $100 | $81.33 | +22.96% | 18 | Oct 27, 2026 | |
| DXCM DexCom | Reiterated: Buy | n/a | $82.29 | - | 41 | Oct 23, 2026 | |
| IART Integra LifeSciences Holdings | Reiterated: Sell | $14 | $12.75 | +9.80% | 7 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $106.20 | +8.29% | 38 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $470 | $432.01 | +8.79% | 47 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $158 | $139.77 | +13.04% | 8 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 → $140 | $119.65 | +17.01% | 10 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $200 | $197.88 | +1.07% | 31 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 | $94.52 | +16.38% | 31 | Sep 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $10.58 | +51.23% | 3 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $29.69 | +1.04% | 9 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $96 → $65 | $59.55 | +9.15% | 4 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $28 | $18.28 | +53.17% | 7 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $106 | $78.05 | +35.81% | 7 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.95 | - | 6 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $28 | $23.00 | +21.74% | 25 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $26.58 | - | 8 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $6.25 | - | 12 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 | $19.11 | +30.82% | 21 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $6.5 | $4.87 | +33.47% | 6 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $39 → $45 | $68.10 | -33.92% | 20 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $21.23 | - | 3 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $86.24 | - | 5 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $44.29 | - | 12 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $92.01 | +8.68% | 31 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $208 | $149.68 | +38.96% | 22 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $318.95 | - | 12 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.20 | - | 1 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $87 | $126.59 | n/a | 1 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $3 | $4.03 | n/a | 6 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.01 | n/a | 5 | Sep 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $24 | $14.98 | n/a | 1 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $22 | $100.46 | n/a | 2 | Sep 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.000001 | n/a | 2 | Aug 7, 2017 |
Boston Scientific
Oct 30, 2026
Reiterated: Buy
Price Target: $54
Current: $41.98
Upside: +28.63%
Medtronic
Oct 30, 2026
Reiterated: Buy
Price Target: $110
Current: $96.54
Upside: +13.94%
Stryker
Oct 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $291.86
Upside: -
Axogen
Oct 29, 2026
Reiterated: Buy
Price Target: $52 → $62
Current: $49.37
Upside: +25.58%
Bausch + Lomb
Oct 29, 2026
Reiterated: Sell
Price Target: n/a
Current: $20.00
Upside: -
GE HealthCare Technologies
Oct 28, 2026
Reiterated: Hold
Price Target: $74 → $84
Current: $76.57
Upside: +9.70%
Beta Bionics
Oct 27, 2026
Reiterated: Hold
Price Target: $20 → $22
Current: $16.75
Upside: +31.34%
Solventum
Oct 27, 2026
Reiterated: Hold
Price Target: $95 → $100
Current: $81.33
Upside: +22.96%
DexCom
Oct 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $82.29
Upside: -
Integra LifeSciences Holdings
Oct 22, 2026
Reiterated: Sell
Price Target: $14
Current: $12.75
Upside: +9.80%
Oct 21, 2026
Reiterated: Buy
Price Target: $115
Current: $106.20
Upside: +8.29%
Oct 21, 2026
Reiterated: Buy
Price Target: $470
Current: $432.01
Upside: +8.79%
Oct 16, 2026
Reiterated: Buy
Price Target: $158
Current: $139.77
Upside: +13.04%
Oct 8, 2026
Reiterated: Buy
Price Target: $120 → $140
Current: $119.65
Upside: +17.01%
Oct 6, 2026
Reiterated: Hold
Price Target: $200
Current: $197.88
Upside: +1.07%
Sep 25, 2026
Reiterated: Hold
Price Target: $110
Current: $94.52
Upside: +16.38%
Sep 17, 2026
Reiterated: Buy
Price Target: $16
Current: $10.58
Upside: +51.23%
Sep 14, 2026
Reiterated: Buy
Price Target: $30
Current: $29.69
Upside: +1.04%
Sep 10, 2026
Downgraded: Hold
Price Target: $96 → $65
Current: $59.55
Upside: +9.15%
Sep 1, 2026
Reiterated: Buy
Price Target: $24 → $28
Current: $18.28
Upside: +53.17%
Aug 19, 2026
Reiterated: Buy
Price Target: $106
Current: $78.05
Upside: +35.81%
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $14.95
Upside: -
Aug 11, 2026
Reiterated: Hold
Price Target: $28
Current: $23.00
Upside: +21.74%
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $26.58
Upside: -
Aug 10, 2026
Reiterated: Sell
Price Target: n/a
Current: $6.25
Upside: -
Aug 7, 2026
Reiterated: Hold
Price Target: $25
Current: $19.11
Upside: +30.82%
Aug 5, 2026
Reiterated: Sell
Price Target: $6.5
Current: $4.87
Upside: +33.47%
Aug 4, 2026
Reiterated: Sell
Price Target: $39 → $45
Current: $68.10
Upside: -33.92%
Aug 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $21.23
Upside: -
Jul 31, 2026
Reiterated: Hold
Price Target: n/a
Current: $86.24
Upside: -
Jul 30, 2026
Reiterated: Sell
Price Target: n/a
Current: $44.29
Upside: -
Jul 21, 2026
Reiterated: Buy
Price Target: $100
Current: $92.01
Upside: +8.68%
Jun 23, 2026
Reiterated: Buy
Price Target: $208
Current: $149.68
Upside: +38.96%
Jan 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $318.95
Upside: -
Nov 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $19.20
Upside: -
Oct 24, 2025
Downgraded: Hold
Price Target: $87
Current: $126.59
Upside: n/a
May 13, 2024
Reiterated: Sell
Price Target: $3
Current: $4.03
Upside: n/a
Sep 29, 2023
Rated: Hold
Price Target: n/a
Current: $3.01
Upside: n/a
Jan 6, 2021
Downgraded: Sell
Price Target: $24
Current: $14.98
Upside: n/a
Sep 27, 2017
Rated: Buy
Price Target: $22
Current: $100.46
Upside: n/a
Aug 7, 2017
Reiterated: Buy
Price Target: n/a
Current: $0.000001
Upside: n/a